Oxycodone HCL-Acetaminophen Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Place of Performance
Hobart, NY, 13788, USASet-Aside
Awardee
Award Issued Date
Timeline
Organization & Contact Information
Full Description
SPE2D2-22-D-0150 P00009 to invoke Option Year 4
SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
SPE2D2-22-D-0150 P00007 to invoke Option Year 3
SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
